Your session is about to expire
← Back to Search
Retrograde Urethrograms for Urethral Stricture
Study Summary
This trial will compare the accuracy of two techniques for diagnosing urethral stricture disease in patients. Results will help determine which technique is more reliable in diagnosing urethral stricture disease.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You currently have a urinary tract infection that has not been treated yet.You have a urethral fistula or need a procedure that uses X-rays to guide it.You have been referred to a urologist for a possible diagnosis of a narrow urethra.
- Group 1: Pulsed Fluoroscopy Retrograde Urethrogram
- Group 2: Traditional Retrograde Urethrogram
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the upper limit of participants enrolled in this clinical investigation?
"Affirmative. The information available on clinicaltrials.gov confirms that this investigation, which was initially posted in September 1st 2022 is actively looking for participants. A total of 46 individuals must be recruited from one medical centre."
Is this research currently enrolling participants?
"Correct. The clinicaltrials.gov platform displays that this medical study, which was initially announced on September 1st 2022, is actively seeking applicants. A total of 46 patients need to be enrolled from one site."
Share this study with friends
Copy Link
Messenger